Pancreatic Cancer: Pancreatica - 2007: April May June

Pancreatic Cancer News and Archives

For access to the Select Abstracts^sm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

2007 Second Quarter

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
June 30, 2007
...more

Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
June 20, 2007
...more

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor-Targeted Therapy for Insulinoma
June 15, 2007
...more

PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) for Patients with Advanced Pancreatic Cancer: The Ghost Regimen
June 8, 2007
...more

A New Liposomal Formulation of Gemcitabine is Active in an Orthotopic Mouse Model of Pancreatic Cancer Accessible to Bioluminescence Imaging
June 7, 2007
...more

Chromogranin A as a Marker of Neuroendocrine Neoplasia: An Italian
Multicenter Study
June 1, 2007
...more

Concurrent Chemoradiotherapy for Advanced Pancreatic Cancer: 1,000 mg/m(2) Gemcitabine can be Administered Using Limited-Field Radiotherapy
June 1, 2007
...more

Dosimetric Feasibility of Hypofractionated Proton Radiotherapy for Neoadjuvant Pancreatic Cancer Treatment
June 1, 2007
...more

Efficient Electrogene Therapy for Pancreatic Adenocarcinoma Treatment Using the Bacterial Purine Nucleoside Phosphorylase Suicide Gene with Fludarabine
June 1, 2007
...more

Gemcitabine Plus Capecitabine Compared with Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
June 1, 2007
...more

Photodynamic Therapy of Malignant Biliary Strictures Using Meso-Tetrahydroxyphenylchlorin
June 1, 2007
...more

Successful Pancreatectomy with En-Bloc Resection of the Celiac Artery and Portal Vein for Pancreatic Endocrine Carcinoma
June 1, 2007
...more

The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic Cancer
June 1, 2007
...more

A Malignant Nonfunctioning Pancreatic Endocrine Tumor with a Unique Pattern of Intraductal Growth
May 29, 2007
...more

Retrospective Analysis of Dual-Phase MDCT and Follow-Up EUS/EUS-FNA in the Diagnosis of Pancreatic Cancer
May 24, 2007
...more

A Late Phase II Study of S-1 for Metastatic Pancreatic Cancer
May 23, 2007
...more

Comparison of (68)Ga-DOTATOC PET and (111)In-DTPAOC (Octreoscan) SPECT in Patients with Neuroendocrine Tumours
May 23, 2007
...more

Erlotinib Plus Gemcitabine Compared with Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
May 20, 2007
...more

Pancreatic VIPomas: Subject Review and One Institutional Experience
May 18, 2007
...more

Effective Treatment of Locally Advanced Endocrine Tumors of the Pancreas with Chemoradiotherapy
May 16, 2007
...more

Temozolomide as Monotherapy is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
May 15, 2007
...more

Oral use of Swedish Moist Snuff (Snus) and Risk for Cancer of the Mouth, Lung, and Pancreas in Male Construction Workers: A Retrospective Cohort Study
May 9, 2007
...more

Passive Smoking and the use of Noncigarette Tobacco Products in Association wth Risk for Pancreatic Cancer: A Case-Control Study
May 9, 2007
...more

K-Ras Oncogene Silencing Strategy Reduces Tumor Growth and Enhances Gemcitabine Chemotherapy Efficacy for Pancreatic Cancer Treatment
May 8, 2007
...more

A Preclinical Evaluation of Pemetrexed and Irinotecan Combination as Second-Line Chemotherapy in Pancreatic Cancer
May 7, 2007
...more

Phase-I Trial of Oral Fluoropyrimidine Anticancer Agent (S-1) with Concurrent Radiotherapy in Patients with Unresectable Pancreatic Cancer
May 7, 2007
...more

Trends in Pancreatic Cancer Incidence in Nine SEER Cancer Registries, 1973-2002
May 7, 2007
...more

Microrna Expression Patterns to Differentiate Pancreatic Adenocarcinoma from Normal Pancreas and Chronic Pancreatitis
May 2, 2007
...more

3,3',5-Triiodo-L-Thyronine Inhibits Ductal Pancreatic Adenocarcinoma Proliferation Improving the Cytotoxic Effect of Chemotherapy
May 1, 2007
...more

Aggressive Pancreatic Resection for Primary Pancreatic Neuroendocrine Tumor: Is it Justifiable?
May 1, 2007
...more

Body Mass Index and Pancreatic Cancer Risk: A Meta-Analysis of Prospective Studies
May 1, 2007
...more

CEACAM1, a Novel Serum Biomarker for Pancreatic Cancer
May 1, 2007
...more

Emerging Therapies for the Treatment of Patients with Advanced Neuroendocrine Tumors
May 1, 2007
...more

Evaluation of Matrix Metalloproteinase 7 in Plasma and Pancreatic Juice as a Biomarker for Pancreatic Cancer
May 1, 2007
...more

Hp39p use of the Superficial Femoral Vein as a Conduit for Portal Vein Reconstruction During Pancreaticoduodenectomy
May 1, 2007
...more

Imatinib Mesylate for Targeting the Platelet-Derived Growth Factor Beta Receptor in Combination with Fluorouracil and Leucovorin in Patients with Refractory Pancreatic, Bile Duct, Colorectal, or Gastric Cancer-A Dose-Escalation Phase I Trial
May 1, 2007
...more

Phase II Trial of Infusional Fluorouracil, Leucovorin, Mitomycin, and Dipyridamole in Locally Advanced Unresectable Pancreatic Adenocarcinoma: SWOG S9700
May 1, 2007
...more

Photodynamic Therapy for Pancreatic Cancer
May 1, 2007
...more

Prognostic Relevance of Lymph Node Ratio Following Pancreaticoduodenectomy for Pancreatic Cancer
May 1, 2007
...more

Virtual Whipple: Preoperative Surgical Planning with Volume-Rendered MDCT Images to Identify Arterial Variants Relevant to the Whipple Procedure
May 1, 2007
...more

Surgery in Malignant Pancreatic Neuroendocrine Tumors
April 27, 2007
...more

A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin
April 24, 2007
...more

Systematic Review, Including Meta-Analyses, on the Management of Locally Advanced Pancreatic Cancer Using Radiation/Combined Modality Therapy
April 23, 2007
...more

Surgical Strategies and Predictors of Outcome for Malignant Neuroendocrine Tumors of the Pancreas
April 19, 2007
...more

Fast Track-Different Implications in Pancreatic Surgery
April 18, 2007
...more

The Gemcitabine, Docetaxel, and Capecitabine (GTX) Regimen for Metastatic Pancreatic Cancer: A Retrospective Analysis
April 18, 2007
...more

Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer Through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-Kappab-Regulated Gene Products
April 15, 2007
...more

Erbb3 Expression and Dimerization with Egfr Influence Pancreatic Cancer Cell Sensitivity to Erlotinib
April 13, 2007
...more

The Role of Intra-Arterial Calcium Stimulation Test with Hepatic Venous Sampling (IACS) in the Management of Occult Insulinomas
April 12, 2007
...more

A Phase I Pilot Study of Autologous Heat Shock Protein Vaccine HSPPC-96 in Patients with Resected Pancreatic Adenocarcinoma
April 10, 2007
...more

CT and MR Imaging Findings of Endocrine Tumor of the Pancreas According to WHO Classification
April 10, 2007
...more

Pancpro: Risk Assessment for Individuals with a Family History of Pancreatic Cancer
April 10, 2007
...more

Differential Diagnosis of Non-Functional Islet Cell Tumor and Pancreatic Carcinoma With Sonography
April 3, 2007
...more

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy And CT
April 1, 2007
...more

A Phase II Trial of Gemcitabine Plus Capecitabine for Patients with Advanced Pancreatic Adenocarcinoma
April 1, 2007
...more

Epidermal Growth Factor Receptor (EGFR) is Highly Conserved in Pancreatic Cancer
April 1, 2007
...more

Evolving Patterns in the Detection and Outcomes of Pancreatic Neuroendocrine Neoplasms: The Massachusetts General Hospital Experience from 1977 to 2005
April 1, 2007
...more

Localisation and Surgical Treatment of Insulinomas
April 1, 2007
...more

Overexpression of the Opioid Growth Factor Receptor Potentiates Growth Inhibition in Human Pancreatic Cancer Cells
April 1, 2007
...more

Phase I Study of Carboplatin in Combination iith Gemcitabine and Irinotecan in Patients with Solid Tumors: Preliminary Evidence of Activity in Small Cell and Neuroendocrine Carcinomas
April 1, 2007
...more

Spiral Saphenous Vein Graft for Portal Vein Reconstruction in Pancreatic Cancer Surgery
April 1, 2007
...more

Surgery for Recurrent Pancreatic Ductal Adenocarcinoma
April 1, 2007
...more

Surgical Approach to Insulinomas: Are Pre-Operative Localisation Tests Necessary?
April 1, 2007
...more

Surgical Treatment of Pancreatic Endocrine Neoplasms
April 1, 2007
...more

The Learning Curve in Pancreatic Surgery
April 1, 2007
...more

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Newswire | Donations
FAQ | Clinical Trials Database | Research Resources | About Us

webmaster

©2000-2008 Pancreatica.org - All Rights Reserved
www.pancreatica.org

	Pancreatic Cancer News and Archives *For access to the Select Abstracts^sm section, please click here* For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer 2007 Second Quarter Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly June 30, 2007 ...more Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer June 20, 2007 ...more [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor-Targeted Therapy for Insulinoma June 15, 2007 ...more PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) for Patients with Advanced Pancreatic Cancer: The Ghost Regimen June 8, 2007 ...more A New Liposomal Formulation of Gemcitabine is Active in an Orthotopic Mouse Model of Pancreatic Cancer Accessible to Bioluminescence Imaging June 7, 2007 ...more Chromogranin A as a Marker of Neuroendocrine Neoplasia: An Italian Multicenter Study June 1, 2007 ...more Concurrent Chemoradiotherapy for Advanced Pancreatic Cancer: 1,000 mg/m(2) Gemcitabine can be Administered Using Limited-Field Radiotherapy June 1, 2007 ...more Dosimetric Feasibility of Hypofractionated Proton Radiotherapy for Neoadjuvant Pancreatic Cancer Treatment June 1, 2007 ...more Efficient Electrogene Therapy for Pancreatic Adenocarcinoma Treatment Using the Bacterial Purine Nucleoside Phosphorylase Suicide Gene with Fludarabine June 1, 2007 ...more Gemcitabine Plus Capecitabine Compared with Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group June 1, 2007 ...more Photodynamic Therapy of Malignant Biliary Strictures Using Meso-Tetrahydroxyphenylchlorin June 1, 2007 ...more Successful Pancreatectomy with En-Bloc Resection of the Celiac Artery and Portal Vein for Pancreatic Endocrine Carcinoma June 1, 2007 ...more The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic Cancer June 1, 2007 ...more A Malignant Nonfunctioning Pancreatic Endocrine Tumor with a Unique Pattern of Intraductal Growth May 29, 2007 ...more Retrospective Analysis of Dual-Phase MDCT and Follow-Up EUS/EUS-FNA in the Diagnosis of Pancreatic Cancer May 24, 2007 ...more A Late Phase II Study of S-1 for Metastatic Pancreatic Cancer May 23, 2007 ...more Comparison of (68)Ga-DOTATOC PET and (111)In-DTPAOC (Octreoscan) SPECT in Patients with Neuroendocrine Tumours May 23, 2007 ...more Erlotinib Plus Gemcitabine Compared with Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group May 20, 2007 ...more Pancreatic VIPomas: Subject Review and One Institutional Experience May 18, 2007 ...more Effective Treatment of Locally Advanced Endocrine Tumors of the Pancreas with Chemoradiotherapy May 16, 2007 ...more Temozolomide as Monotherapy is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors May 15, 2007 ...more Oral use of Swedish Moist Snuff (Snus) and Risk for Cancer of the Mouth, Lung, and Pancreas in Male Construction Workers: A Retrospective Cohort Study May 9, 2007 ...more Passive Smoking and the use of Noncigarette Tobacco Products in Association wth Risk for Pancreatic Cancer: A Case-Control Study May 9, 2007 ...more K-Ras Oncogene Silencing Strategy Reduces Tumor Growth and Enhances Gemcitabine Chemotherapy Efficacy for Pancreatic Cancer Treatment May 8, 2007 ...more A Preclinical Evaluation of Pemetrexed and Irinotecan Combination as Second-Line Chemotherapy in Pancreatic Cancer May 7, 2007 ...more Phase-I Trial of Oral Fluoropyrimidine Anticancer Agent (S-1) with Concurrent Radiotherapy in Patients with Unresectable Pancreatic Cancer May 7, 2007 ...more Trends in Pancreatic Cancer Incidence in Nine SEER Cancer Registries, 1973-2002 May 7, 2007 ...more Microrna Expression Patterns to Differentiate Pancreatic Adenocarcinoma from Normal Pancreas and Chronic Pancreatitis May 2, 2007 ...more 3,3',5-Triiodo-L-Thyronine Inhibits Ductal Pancreatic Adenocarcinoma Proliferation Improving the Cytotoxic Effect of Chemotherapy May 1, 2007 ...more Aggressive Pancreatic Resection for Primary Pancreatic Neuroendocrine Tumor: Is it Justifiable? May 1, 2007 ...more Body Mass Index and Pancreatic Cancer Risk: A Meta-Analysis of Prospective Studies May 1, 2007 ...more CEACAM1, a Novel Serum Biomarker for Pancreatic Cancer May 1, 2007 ...more Emerging Therapies for the Treatment of Patients with Advanced Neuroendocrine Tumors May 1, 2007 ...more Evaluation of Matrix Metalloproteinase 7 in Plasma and Pancreatic Juice as a Biomarker for Pancreatic Cancer May 1, 2007 ...more Hp39p use of the Superficial Femoral Vein as a Conduit for Portal Vein Reconstruction During Pancreaticoduodenectomy May 1, 2007 ...more Imatinib Mesylate for Targeting the Platelet-Derived Growth Factor Beta Receptor in Combination with Fluorouracil and Leucovorin in Patients with Refractory Pancreatic, Bile Duct, Colorectal, or Gastric Cancer-A Dose-Escalation Phase I Trial May 1, 2007 ...more Phase II Trial of Infusional Fluorouracil, Leucovorin, Mitomycin, and Dipyridamole in Locally Advanced Unresectable Pancreatic Adenocarcinoma: SWOG S9700 May 1, 2007 ...more Photodynamic Therapy for Pancreatic Cancer May 1, 2007 ...more Prognostic Relevance of Lymph Node Ratio Following Pancreaticoduodenectomy for Pancreatic Cancer May 1, 2007 ...more Virtual Whipple: Preoperative Surgical Planning with Volume-Rendered MDCT Images to Identify Arterial Variants Relevant to the Whipple Procedure May 1, 2007 ...more Surgery in Malignant Pancreatic Neuroendocrine Tumors April 27, 2007 ...more A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin April 24, 2007 ...more Systematic Review, Including Meta-Analyses, on the Management of Locally Advanced Pancreatic Cancer Using Radiation/Combined Modality Therapy April 23, 2007 ...more Surgical Strategies and Predictors of Outcome for Malignant Neuroendocrine Tumors of the Pancreas April 19, 2007 ...more Fast Track-Different Implications in Pancreatic Surgery April 18, 2007 ...more The Gemcitabine, Docetaxel, and Capecitabine (GTX) Regimen for Metastatic Pancreatic Cancer: A Retrospective Analysis April 18, 2007 ...more Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer Through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-Kappab-Regulated Gene Products April 15, 2007 ...more Erbb3 Expression and Dimerization with Egfr Influence Pancreatic Cancer Cell Sensitivity to Erlotinib April 13, 2007 ...more The Role of Intra-Arterial Calcium Stimulation Test with Hepatic Venous Sampling (IACS) in the Management of Occult Insulinomas April 12, 2007 ...more A Phase I Pilot Study of Autologous Heat Shock Protein Vaccine HSPPC-96 in Patients with Resected Pancreatic Adenocarcinoma April 10, 2007 ...more CT and MR Imaging Findings of Endocrine Tumor of the Pancreas According to WHO Classification April 10, 2007 ...more Pancpro: Risk Assessment for Individuals with a Family History of Pancreatic Cancer April 10, 2007 ...more Differential Diagnosis of Non-Functional Islet Cell Tumor and Pancreatic Carcinoma With Sonography April 3, 2007 ...more 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy And CT April 1, 2007 ...more A Phase II Trial of Gemcitabine Plus Capecitabine for Patients with Advanced Pancreatic Adenocarcinoma April 1, 2007 ...more Epidermal Growth Factor Receptor (EGFR) is Highly Conserved in Pancreatic Cancer April 1, 2007 ...more Evolving Patterns in the Detection and Outcomes of Pancreatic Neuroendocrine Neoplasms: The Massachusetts General Hospital Experience from 1977 to 2005 April 1, 2007 ...more Localisation and Surgical Treatment of Insulinomas April 1, 2007 ...more Overexpression of the Opioid Growth Factor Receptor Potentiates Growth Inhibition in Human Pancreatic Cancer Cells April 1, 2007 ...more Phase I Study of Carboplatin in Combination iith Gemcitabine and Irinotecan in Patients with Solid Tumors: Preliminary Evidence of Activity in Small Cell and Neuroendocrine Carcinomas April 1, 2007 ...more Spiral Saphenous Vein Graft for Portal Vein Reconstruction in Pancreatic Cancer Surgery April 1, 2007 ...more Surgery for Recurrent Pancreatic Ductal Adenocarcinoma April 1, 2007 ...more Surgical Approach to Insulinomas: Are Pre-Operative Localisation Tests Necessary? April 1, 2007 ...more Surgical Treatment of Pancreatic Endocrine Neoplasms April 1, 2007 ...more The Learning Curve in Pancreatic Surgery April 1, 2007 ...more

	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer


	Home \| In The News \| Links \| Newswire \| Donations FAQ \| Clinical Trials Database \| Research Resources \| About Us

	webmaster

	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org